In June the World Health Organization (WHO) published a new classification of antibiotics aimed at fighting drug resistance, with penicillin-type drugs recommended as the first line of defense, and others only when absolutely necessary. [1]
The World Health Organization (WHO) is warning that antibiotic-resistant strains of gonorrhea are on the rise, and about 78 million people per year could be at risk for the sexually-transmitted disease (STD). [1]
In a recent report, the WHO explains how researchers looked at data from gonorrhea cases and antibiotic resistance from 77 countries. Of those countries:
On July 26, the U.S. Food and Drug Administration (FDA) bolstered the warnings concerning a certain class of antibiotics, called fluoroquinolones, saying they’re too strong for bronchitis, sinus infections, and simple urinary tract infections.
